Stem cell sheet therapy: another option for acute kidney injury?
Level V
Where this comes from
- Record sourced from PubMed, PMID 33390229.
- Also identified by DOI 10.1016/j.kint.2020.08.034.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent advances in material engineering and gene editing techniques have now made it possible to use sheeted stem cells as distributors of therapeutic factors in clinical practice (e.g., as beating sheets for patients with heart failure). In this issue, Park et al. report the effects of sheets of genome-engineered human umbilical cord-derived mesenchymal stem cells in preserving kidney function after ischemia-reperfusion injury, demonstrating a possible application for acute kidney injury treatment.
Medical subject headings
- Acute Kidney Injury
- Mesenchymal Stem Cell Transplantation
- Mesenchymal Stem Cells
- Reperfusion Injury